Annexon Highlights Pivotal Data on First Potential Targeted Therapy for Guillain-Barr Syndrome (GBS) and Showcases New GBS Education Campaign at American Academy of Neurology (AAN) 2025 Annual Meeting
April 08, 2025 16:05 ET | Source: Annexon Biosciences Oral Presentation Features…
Huawei Recognized as a Leader in the 2025 Gartner Magic Quadrant for Data Center Switching
SHENZHEN, China, April 7, 2025 /PRNewswire/ -- Gartner has released its 2025…
IBM Acquires Hakkoda Inc., Expanding Data Expertise to Fuel Clients’ AI Transformations
ARMONK, N.Y., April 7, 2025 /PRNewswire/ -- IBM (NYSE: IBM) today announced…
iBio Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim In Vivo Results for First-in-Class Activin E Antibody, Advancing Cardiometabolic and Obesity Pipeline
Non-human primate pharmacokinetics data suggests IBIO-600, a potentially best-in-class long-acting anti-myostatin antibody,…
LG U+ Uses Denodo Platform to Build Modern, Integrated Data Management Infrastructure
SEOUL, South Korea, April 07, 2025 (GLOBE NEWSWIRE) -- Denodo, a leader…
Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025
April 04, 2025 08:30 ET | Source: Xenon Pharmaceuticals Inc. Three epilepsy…
Ascenty Applauded by Frost & Sullivan for Delivering Future-Ready, World-Class Data Center Infrastructure Solutions and Its Market-Leading Position
Ascenty operated 24 data centers in 2024, has a proprietary fiber-optic network,…
EDGNEX Data Centers by DAMAC Confirms Strategic Partnership with Nordic Data Center Developer Hyperco
New acquisition in Nordics is part of the company's ambitious European and global…
Anthos Therapeutics Shares New Data from the Landmark AZALEA-TIMI 71 Study Demonstrating the Factor XI Inhibitor Abelacimab Significantly Reduced Bleeding in Patients Regardless of Age or Bleeding Risk
--Data presented at the American College of Cardiology Annual Scientific Session show…
Mineralys Therapeutics Announces Late-Breaking Data from Advance-HTN Pivotal Trial of Lorundrostat in Uncontrolled and Resistant Hypertension Presented at the American College of Cardiologys Annual Scientific Session & Expo (ACC.25)
– Lorundrostat 50 mg dose achieved a 15.4 mmHg absolute reduction and…